Abstract
Rationale
Sugar has addictive potential owing to increase in monoaminergic-transmission at pleasure and reward centers of brain. Insulin dysfunction triggered synaptic monoamine deficit is associated with sugar overeating and craving-related psychological changes in diabetic patients. Sugar-substitute (saccharin) is non-caloric artificial sweetener that may alleviate brain disorders in diabetes.
Objectives
In present study, effects of sucrose and sugar-substitute (saccharin) exposures and withdrawal on depression and anxiety-like behavior in type 2 diabetic mice were assessed.
Methods
Swiss albino mice were injected with streptozotocin (135 mg/kg). After induction of diabetes, mice were exposed to a two-bottle water-water, 10% sucrose-water, or 10% saccharin-water choice paradigm for 28 days. Separate groups were employed to assess withdrawal effect of sucrose or saccharin in diabetic mice. Monoamine oxidase (MAO), corticosterone, thiobarbituric acid reactive substances (TBARS), and reduced glutathione (GSH) were quantified after behavioral tests.
Results
Diabetic mice manifested preference towards 10% sucrose or saccharin over water. Sucrose-overeating by diabetic mice amplified symptoms of depression and anxiety; however, withdrawal further exaggerated these behavioral abnormalities. Substitution of sucrose by 10% saccharin attenuated the depressive and anxiety-like behavior in comparison to diabetic mice that were exposed separately to water-water or sucrose-water alone, and with respect to normal mice. Although withdrawal from saccharin resurfaced behavioral anomalies in diabetic mice, however, these were significantly low in comparison with withdrawal from sucrose or normal group. Reinstatement of exposure to saccharin mitigated symptoms of depression and anxiety in diabetic mice.
Conclusion
Preference of sucrose overeating augments while saccharin mitigates depressive and anxiety behavior during diabetes.
Similar content being viewed by others
References
Adamantidis AR, Tsai HC, Boutrel B, Zhang F, Stuber GD, Budygin EA, Tourino C, Bonci A, Deisseroth K, de Lecea L (2011) Optogenetic interrogation of dopaminergic modulation of the multiple phases of reward-seeking behavior. J Neurosci 31(30):10829–10835. https://doi.org/10.1523/JNEUROSCI.2246-11.2011
Ahmed SH, Guillem K, Vandaele Y (2013) Sugar addiction: pushing the drug-sugar analogy to the limit. Curr Opin Clin Nutr Metab Care 16(4):434–439. https://doi.org/10.1097/MCO.0b013e328361c8b8
Avena NM, Rada P, Hoebel BG (2008) Evidence for sugar addiction: behavioral and neurochemical effects of intermittent, excessive sugar intake. Neurosci Biobehav Rev 32(1):20–39. https://doi.org/10.1016/j.neubiorev.2007.04.019
Badescu SV, Tataru C, Kobylinska L, Georgescu EL, Zahiu DM, Zagrean AM, Zagrean L (2016) The association between diabetes mellitus and depression. J Med Life 9(2):120–125
Bajpai A, Verma AK, Srivastava M, Srivastava R (2014) Oxidative stress and major depression. J Clin Diagn Res 8(12):CC04–CC07. https://doi.org/10.7860/JCDR/2014/10258.5292
Bartos J, Pesez M (1979) Colorimetric and fluorimetric determination of steroids. Pure Appl Chem 51(10):2157–2159
Belzer LM, Smulian JC, Lu SE, Tepper BJ (2010) Food cravings and intake of sweet foods in healthy pregnancy and mild gestational diabetes mellitus. A prospective study. Appetite 55(3):609–615. https://doi.org/10.1016/j.appet.2010.09.014
Berridge KC, Ho CY, Richard JM, DiFeliceantonio AG (2010) The tempted brain eats: pleasure and desire circuits in obesity and eating disorders. Brain Res 1350:43–64. https://doi.org/10.1016/j.brainres.2010.04.003
Bouayed J, Rammal H, Soulimani R (2009) Oxidative stress and anxiety: relationship and cellular pathways. Oxidative Med Cell Longev 2(2):63–67. https://doi.org/10.4161/oxim.2.2.7944
Brigitta B (2002) Pathophysiology of depression and mechanisms of treatment. Dialogues Clin Neurosci 4(1):7–20
Chan O, Inouye K, Vranic M, Matthews SG (2002) Hyperactivation of the hypothalamo-pituitary-adrenocortical axis in streptozotocin-diabetes is associated with reduced stress responsiveness and decreased pituitary and adrenal sensitivity. Endocrinology 143(5):1761–1768. https://doi.org/10.1210/endo.143.5.8809
Chappel CI (1992) A review and biological risk assessment of sodium saccharin. Regul Toxicol Pharmacol 15(3):253–270
Chattopadhyay S, Raychaudhuri U, Chakraborty R (2011) Artificial sweeteners - a review. J Food Sci Technol 51(4):611–621. https://doi.org/10.1007/s13197-011-0571-1
Correia S, Carvalho C, Santos MS, Proença T, Nunes E, Duarte AI, Monteiro P, Seiça R, Oliveira CR, Moreira PI (2008) Metformin protects the brain against the oxidative imbalance promoted by type 2 diabetes. Med Chem 4(4):358–364. https://doi.org/10.2174/157340608784872299
Cryan JF, Mombereau C, Vassout A (2005) The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev 29(4–5):571–625. https://doi.org/10.1016/j.neubiorev.2005.03.009
Domingos AI, Vaynshteyn J, Voss HU, Ren X, Gradinaru V, Zang F, Deisseroth K, de Araujo IE, Friedman J (2011) Leptin regulates the reward value of nutrient. Nat Neurosci 14:1562–1568. https://doi.org/10.1038/nn.2977
Drewnowski A, Krahn DD, Demitrack MA, Nairn K, Gosnell BA (1995) Naloxone, an opiate blocker, reduces the consumption of sweet high-fat foods in obese and lean female binge eaters. Am J Clin Nutr 61(6):1206–1212. https://doi.org/10.1093/ajcn/61.6.1206
Drewnowski A, Mennella JA, Johnson SL, Bellisle F (2012) Sweetness and food preference. J Nutr 142(6):1142S–1148S. https://doi.org/10.3945/jn.111.149575
Eleazu CO, Eleazu KC, Chukwuma S, Essien UN (2013) Review of the mechanism of cell death resulting from streptozotocin challenge in experimental animals, its practical use and potential risk to humans. J Diabetes Metab Disord 12(1):60. https://doi.org/10.1186/2251-6581-12-60
Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82:70–77. https://doi.org/10.1016/0003-9861(59)90090-6
Ellwein LB, Cohen SM (1990) The health risks of saccharin revisited. Crit Rev Toxicol 20(5):311–326
Gawryluk JW, Wang JF, Andreazza AC, Shao L, Young LT (2011) Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders. Int J Neuropsychopharmacol 14(1):123–130. https://doi.org/10.1017/S1461145710000805
Gilhotra N, Dhingra D (2009) Involvement of NO-cGMP pathway in anti-anxiety effect of aminoguanidine in stressed mice. Prog Neuro-Psychopharmacol Biol Psychiatry 33(8):1502–1507. https://doi.org/10.1016/j.pnpbp.2009.08.012
Gupta D, Kurhe Y, Radhakrishnan M (2014) Antidepressant effects of insulin in streptozotocin induced diabetic mice: modulation of brain serotonin system. Physiol Behav 129:73–78. https://doi.org/10.1016/j.physbeh.2014.02.036
Hasler G (2010) Pathophysiology of depression: do we have any solid evidence of interest to clinicians? World Psychiatry 9(3):155–161. https://doi.org/10.1002/j.2051-5545.2010.tb00298.x
Hassan W, Silva CEB, Mohammadzai IU, da Rocha JBT, Landeira-Fernandez J (2014) Association of oxidative stress to the genesis of anxiety: implications for possible therapeutic interventions. Curr Neuropharmacol 12(2):120–139. https://doi.org/10.2174/1570159X11666131120232135
Jastreboff AM, Sinha R, Arora J, Giannini C, Kubat J, Malik S, Michelle A, Santoro N, Savoye M, Duran EJ, Pierpont B, Cline G, Todd R, Sherwin RS, Caprio S (2016) Altered brain response to drinking glucose and fructose in obese adolescents. Diabetes 65(7):1929–1939. https://doi.org/10.2337/db15-1216
Karten YJ, Nair SM, van Essen L, Sibug R, Joels M (1999) Long-term exposure to high corticosterone levels attenuates serotonin responses in rat hippocampal CA1 neurons. Proc Natl Acad Sci U S A 96(23):13456–13461. https://doi.org/10.1073/pnas.96.23.13456
Kim S, Shou J, Abera S, Ziff EB (2018) Sucrose withdrawal induces depression and anxiety-like behaviour by Kir 2.1 upregulation in the nucleus accumbens. Neuropharmacology 130:10–17. https://doi.org/10.1016/j.neuropharm.2017.11.041
Kleinridders A, Cai W, Cappellucci L, Ghazarian A, Collins WR, Vienberg SG, Pothos EN, Kahn CR (2015) Insulin resistance in brain alters dopamine turnover and causes behavioral disorders. Proc Natl Acad Sci U S A 112(11):3463–3468. https://doi.org/10.1073/pnas.1500877112
Krolow R, Arcego DM, Noschang C, Weis SN, Dalmaz C (2014) Oxidative imbalance and anxiety disorders. Curr Neuropharmacol 12(2):193–204. https://doi.org/10.2174/1570159X11666131120223530
Lakhman SS, Kaur G (1997) Effect of experimental diabetes on monoamine oxidase activity from discrete areas of rat brain: relationship with diabetes associated reproductive failure. Mol Cell Biochem 177(1–2):15–20. https://doi.org/10.1023/A:1006851426257
Lenoir M, Serre F, Cantin L, Ahmed SH (2007) Intense sweetness surpasses cocaine reward. PLoS One 2:e698. https://doi.org/10.1371/journal.pone.0000698
Liu T, Zhong S, Liao X, Chen J, He T, Lai S, Jia Y (2015) A meta-analysis of oxidative stress markers in depression. PLoS One 10(10):e0138904. https://doi.org/10.1371/journal.pone.0138904
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
Lustig RH (2010) Fructose: metabolic, hedonic, and societal parallels with ethanol. J Am Diet Assoc 110(9):1307–1321. https://doi.org/10.1016/j.jada.2010.06.008
Maone TR, Mattes RD, Bernbaum JC, Beauchamp GK (1990) A new method for delivering a taste without fluids to preterm and term infants. Dev Psychobiol 23:179–191
Meyer JH, Ginovart N, Boovariwala A, Sagrati S, Hussey D, Garcia A, Young T, Praschak-Rieder N, Wilson AA, Houle S (2006) Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression. Arch Gen Psychiatry 63(11):1209–1216. https://doi.org/10.1001/archpsyc.63.11.1209
Mitra R, Sapolsky RM (2008) Acute corticosterone treatment is sufficient to induce anxiety and amygdaloid dendritic hypertrophy. Proc Natl Acad Sci U S A 105(14):5573–5578. https://doi.org/10.1073/pnas.0705615105
Mukherjee B, Mukherjee JR, Chatterjee M (1994) Lipid peroxidation, glutathione levels and changes in glutathione-related enzyme activities in streptozotocin-induced diabetic rats. Immunol Cell Biol 72(2):109–114. https://doi.org/10.1038/icb.1994.17
Naicker K, Johnson JA, Skogen JC, Manuel D, Overland S, Sivertsen B, Colman I (2017) Type 2 diabetes and comorbid symptoms of depression and anxiety: longitudinal associations with mortality risk. Diabetes Care 40(3):352–358. https://doi.org/10.2337/dc16-2018
Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358. https://doi.org/10.1016/0003-2697(79)90738-3
Olivier B, Serge AH, Catherine A, Belegaud J, Bortolotti M, Canivenc-Lavier MC, Charriere S, Girardet J-P, Houdart S, Kalonji E, Nadaud P, Rajas F, Slama G, Margaritis I (2015) Review of the nutritional benefits and risks related to intense sweeteners. Arch Public Health 73(41):41. https://doi.org/10.1186/s13690-015-0092-x
Page KA, Chan O, Arora J, Deaguiar RB, Dzuira J, Roehmholdt B, Cline GW, Naik S, Sinha R, Constable RT, Sherwin RS (2013) Effects of fructose vs glucose on regional cerebral blood flow in brain regions involved with appetite and reward pathways. JAMA 309(1):63–70. https://doi.org/10.1001/jama.2012.116975
Palizgir M, Bakhtiari M, Esteghamati A (2013) Association of depression and anxiety with diabetes mellitus type 2 concerning some sociological factors. Iran Red Crescent Med J 15(8):644–648. https://doi.org/10.5812/ircmj.12107
Porsolt RD, Bertin A, Jalfre M (1977) Behavioural despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229(2):327–336
Prpic-Krizevac I, Canecki-Varzic S, Bilic-Curcic I (2012) Hyperactivity of the hypothalamic-pituitary-adrenal axis in patients with type 2 diabetes and relations with insulin resistance and chronic complications. Wien Klin Wochenschr 124(11–12):403–411. https://doi.org/10.1007/s00508-012-0191-4
Rajput R, Gehlawat P, Gehlan D, Gupta R, Rajput M (2016) Prevalence and predictors of depression and anxiety in patients of diabetes mellitus in a tertiary care center. Indian J Endocrinol Metab 20(6):746–751. https://doi.org/10.4103/2230-8210.192924
Raza H, John A, Howarth FC (2015) Increased oxidative stress and mitochondrial dysfunction in zucker diabetic rat liver and brain. Cell Physiol Biochem 35(3):1241–1251. https://doi.org/10.1159/000373947
Ritov VB, Menshikova EV, Azuma K, Wood R, Toledo FG, Goodpaster BH, Ruderman NB, Kelley DE (2010) Deficiency of electron transport chain in human skeletal muscle mitochondria in type 2 diabetes mellitus and obesity. Am J Physiol Endocrinol Metab 298(1):E49–E58. https://doi.org/10.1152/ajpendo.00317.2009
Roy M, Collier B, Roy A (1990) Hypothalamic-pituitary-adrenal axis dysregulation among diabetic outpatients. Psychiatry Res 31(1):31–37. https://doi.org/10.1016/0165-1781(90)90106-F
Salim S (2014) Oxidative stress and psychological disorders. Curr Neuropharmacol 12(2):140–147. https://doi.org/10.2174/1570159X11666131120230309
Sandhir R, Mehrotra A, Kamboj SS (2010) Lycopene prevents 3-nitropropionic acid-induced mitochondrial oxidative stress and dysfunctions in nervous system. Neurochem Int 57(5):579–587. https://doi.org/10.1016/j.neuint.2010.07.005
Sharma R, Buras E, Terashima T, Serrano F, Massaad CA, Hu L, Bitner B, Inoue T, Chan L, Pautler RG (2010a) Hyperglycemia induces oxidative stress and impairs axonal transport rates in mice. PLoS One 5(10):e13463. https://doi.org/10.1371/journal.pone.0013463
Sharma AN, Elased KM, Garrett TL, Lucot JB (2010b) Neurobehavioral deficits in db/db diabetic mice. Physiol Behav 101(3):381–388. https://doi.org/10.1016/j.physbeh.2010.07.002
Sharma S, Fernandes MF, Fulton S (2013) Adaptations in brain reward circuitry underlie palatable food cravings and anxiety induced by high-fat diet withdrawal. Int J Obes 37:1183–1191. https://doi.org/10.1038/ijo.2012.197
Skorzewska A, Lehner M, Wislowska-Stanek A, Krząscik P, Ziemba A, Płaznik A (2014) The effect of chronic administration of corticosterone on anxiety- and depression-like behavior and the expression of GABA-A receptor alpha-2 subunits in brain structures of low- and high-anxiety rats. Horm Behav 65(1):6–13. https://doi.org/10.1016/j.yhbeh.2013.10.011
Spiers JG, Chen HJ, Sernia C, Lavidis NA (2015) Activation of the hypothalamic-pituitary-adrenal stress axis induces cellular oxidative stress. Front Neurosci 8(456). https://doi.org/10.3389/fnins.2014.00456
Steiner JE, Glaser D, Hawilo ME, Berridge KC (2001) Comparative expression of hedonic impact: affective reactions to taste by human infants and other primates. Neurosci Biobehav Rev 25:53–74. https://doi.org/10.1016/S0149-7634(00)00051-8
Steru L, Chermat R, Thierry B, Simon P (1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 85(3):367–370. https://doi.org/10.1007/BF00428203
Valecha R, Dhingra D (2016) Behavioral and biochemical evidences for antidepressant-like activity of Celastrus paniculatus seed oil in mice. Basic Clin Neurosci 7(1):49–56
Van Herck H, Baumans V, De Boer SF, Van der Gugten J, Van Woerkom AB, Beynen AC (1991) Endocrine stress response in rats subjected to singular orbital puncture while under diethyl-ether anesthesia. Lab Anim 25(4):325–329. https://doi.org/10.1258/002367791780809931
Vavakova M, Durackova Z, Trebaticka J (2015) Markers of oxidative stress and neuroprogression in depression disorder. Oxidative Med Cell Longev 898393:1–12. https://doi.org/10.1155/2015/898393
Wallace DL, Vialou V, Rios L, Carle-Florence TL, Chakravarty S, Kumar A, Graham DL, Green TA, Kirk A, Iniquez SD, Perrotti LI, Barrot M, Dileone RJ, Nestler EJ, Bolanos-Guzman CA (2008) The influence of deltaFosB in the nucleus accumbens on natural reward-related behaviour. J Neurosci 28(41):10272–10277. https://doi.org/10.1523/JNEUROSCI.1531-08.2008
Watson S, Gallagher P, Smith MS, Ferrier IN, Young AH (2006) The dex/CRH test-is it better than the DST? Psychoneuroendocrinology 31(7):889–894. https://doi.org/10.1016/j.psyneuen.2006.03.001
Wender EH, Solanto MV (1991) Effects of sugar on aggressive and inattentive behavior in children with attention deficit disorder with hyperactivity and normal children. Pediatrics 88(5):960–966
Wurtman RJ, Wurtman JJ (1986) Carbohydrate craving, obesity and brain serotonin. Appetite 7:99–103. https://doi.org/10.1016/S0195-6663(86)80055-1
Wurtman RJ, Wurtman JJ (1988) Do carbohydrates affect food intake via neurotransmitter activity? Appetite 11(1):42–47. https://doi.org/10.1016/S0195-6663(88)80045-X
Wurtman RJ, Wurtman JJ (1995) Brain serotonin, carbohydrate-craving, obesity and depression. Obes Res 3(4):477S–480S. https://doi.org/10.1002/j.1550-8528.1995.tb00215.x
Yu ZF, Kong LD, Chen Y (2002) Antidepressant activity of aqueous extracts of Curcuma longa in mice. J Ethnopharmacol 83(1–2):161–165. https://doi.org/10.1016/S0378-8741(02)00211-8
Yu R, Y-Hua L, Hong L (2010) Depression in newly diagnosed type 2 diabetes. Int J Diabetes Dev Ctries 30(2):102–104. https://doi.org/10.4103/0973-3930.62601
Zheng G, Mo F, Ling C, Peng H, Gu W, Li M, Chen Z (2017) Portulaca oleracea L. alleviates liver injury in streptozotocin induced diabetic mice. Drug Des Devel Ther 12:47–55. https://doi.org/10.2147/DDDT.S121084
Acknowledgments
The authors are thankful to the management of Swift School of Pharmacy, Rajpura, for providing necessary research facilities.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Animal procedures were carried out in accordance with the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA), Ministry of Environment, Forests and Climate Change, Govt. of India (New Delhi), approved by the Institutional Animal Ethics Committee (IAEC).
Conflict of interests
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kumar, M., Chail, M. Sucrose and saccharin differentially modulate depression and anxiety-like behavior in diabetic mice: exposures and withdrawal effects. Psychopharmacology 236, 3095–3110 (2019). https://doi.org/10.1007/s00213-019-05259-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-019-05259-3